Plasmonic Fluorescent Nanocomposites for High-Sensitivity Bioassays
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current fluorescence-based bioassays are limited by weak fluorescence signals and poor signal-to-noise ratios, which restrict their detection sensitivity, and existing solutions like improved instrumentation or complex amplification schemes are costly or have limited dynamic range.
Innovation Solution
Development of ultrabright fluorescent nanoconstructs comprising plasmonic nanostructures coated with fluorescent agents and biorecognition elements, such as silver-coated gold nanorods, to enhance fluorescence intensity and enable simpler, less expensive detection systems.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Illumination intensity
If conventional fluorescent probes are used in bioassays, then the assays can be performed with standard instrumentation, but the fluorescence signal is weak and the signal-to-noise ratio is poor
Solution Approach 1:
The patent employs composite fluorescent nanoprobes consisting of fluorescent molecules combined with metallic nanoparticles (gold, silver, or copper). The metallic component enhances the fluorescence signal through plasmonic effects, while the fluorescent component provides the optical activity. This composite structure achieves both high fluorescence intensity and improved signal-to-noise ratio without requiring complex instrumentation.
Solution Approach 2:
The patent modifies the optical parameters of the fluorescent probes by introducing plasmonic metallic nanoparticles that alter the local electromagnetic field. This changes the excitation and emission characteristics of the fluorescent molecules, resulting in enhanced fluorescence intensity and improved detection sensitivity while maintaining compatibility with standard instrumentation.
2Measurement precision
If detection instrumentation is improved with more sensitive detectors and higher numerical aperture optical systems, then detection sensitivity increases, but the equipment expense increases greatly and the field-of-view is significantly limited
Solution Approach 1:
Instead of improving the instrumentation, the patent changes the parameters of the fluorescent probes themselves by incorporating plasmonic metallic nanoparticles. This approach enhances the fluorescence signal at the source, allowing standard detectors to achieve high detection sensitivity without requiring expensive high-numerical-aperture optical systems or specialized equipment.
3Measurement precision
If complex amplification schemes like poly-HRP, PCR-ELISA, or tyramide signal amplification are employed, then fluorescence detection sensitivity is improved, but the assay complexity and expense increase
Solution Approach 1:
The patent achieves enhanced fluorescence detection sensitivity through intrinsic parameter changes in the probe design (plasmonic enhancement) rather than through complex signal amplification workflows. This eliminates the need for multi-step amplification schemes like poly-HRP or tyramide signal amplification, resulting in simpler, faster, and equally sensitive assays.
Solution Approach 2:
The patent extracts the essential function of signal amplification from complex multi-step workflows and integrates it directly into the probe structure through plasmonic metallic nanoparticles. This consolidation eliminates unnecessary intermediate steps and reagents while maintaining or improving detection sensitivity.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The nanoconstructs achieve a fluorescence intensity at least 500 times greater than individual fluorescent agents, allowing for higher detection sensitivity and multiplexing capabilities in bioassays, particularly in identifying T-cell receptors, without the need for expensive equipment or complicated workflows.
Implementation Method 1
a plasmonic nanostructure having at least one localized surface plasmon resonance wavelength (λLSPR)... The fluorescent nanocomposite structure has a fluorescent intensity that is at least 500 times greater than a fluorescent intensity of the at least one fluorescent agent alone
Data Source
AI summary
Described herein is a fluorescent nanocomposite. The fluorescent nanocomposite structure may include a plasmonic nanostructure comprising having at least one localized surface plasmon resonance wavelength (λLSPR), at least one spacer coating, at least one fluorescent agent having a maximum excitation wavelength (λEX), and at least one peptide-loaded major histocompatibility complex (MHC) molecule (pMHC). The fluorescent nanocomposite structure has a fluorescent intensity that is at least 500 times greater than a fluorescent intensity of the at least one fluorescent agent alone.